F10 and osteoporosis: However, most inhibitors of thrombin and FXa, or thrombolytic agents, have side effects, such as hepatotoxicity, renal impairment, thrombocytopenia, osteoporosis, low specificity, decreased platelet or white cell numbers, platelet purpura, and bleeding complications [50,51,52,53].